Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice.
about
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.Hypertension in mice lacking the proatrial natriuretic peptide convertase corinNatriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart.Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heartB-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension.Asiatic acid inhibits cardiac hypertrophy by blocking interleukin-1β-activated nuclear factor-κB signaling in vitro and in vivo.Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival.Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction.Onset and Regression of Pregnancy-Induced Cardiac Alterations in Gestationally Hypertensive Mice: The Role of the Natriuretic Peptide System.Molecular pathways underlying cardiac remodeling during pathophysiological stimulation.The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.Gestational hypertension and the developmental origins of cardiac hypertrophy and diastolic dysfunction.Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.Maternal hypertension programs increased cerebral tissue damage following stroke in adult offspring.
P2860
Q28082833-8A1DF5BB-77AC-486A-9484-31B6E1CC7919Q28569799-B7E492E4-8156-468E-BD21-A7A2AA48A7A8Q28590173-931948C6-E571-4759-A327-0399EE17205EQ33578038-3D196235-00AC-4E45-BDEA-8A7C4C8A0588Q33656046-60A8E810-BF84-4C96-A93C-B2E33EFB00B6Q35742577-1E91D59B-A302-4E76-8E70-52A71481743BQ36254463-3C2BC3CA-E168-4BB1-8C28-FF6EDE32A11FQ36506117-1B1FA44B-0F80-49F3-B3B9-7C5FC752252FQ37354583-FE90F1F2-6BDE-494C-9676-71E20B80FF48Q37476523-73DEC6DA-50E6-48A5-B3B6-A502531919ACQ40356250-A27B94A1-6800-4B77-BAFA-ADD6E826A8F5Q41855920-F0D2A1A4-8E80-40E3-967F-85E4ACB69063Q44729962-DE5F6632-C1BD-424B-BDD9-FE0D98893415Q46051964-6908600F-B12A-43D6-845B-00449B514765Q50724294-9942B775-C214-4425-A99D-6B2D23B57C1FQ52661821-86A5C609-0C9A-4A15-921F-7652CC04EAC9
P2860
Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Pressure-independent enhanceme ...... uretic peptide-deficient mice.
@en
Pressure-independent enhanceme ...... uretic peptide-deficient mice.
@nl
type
label
Pressure-independent enhanceme ...... uretic peptide-deficient mice.
@en
Pressure-independent enhanceme ...... uretic peptide-deficient mice.
@nl
prefLabel
Pressure-independent enhanceme ...... uretic peptide-deficient mice.
@en
Pressure-independent enhanceme ...... uretic peptide-deficient mice.
@nl
P2093
P2860
P1476
Pressure-independent enhanceme ...... uretic peptide-deficient mice.
@en
P2093
Gilbert Perry
Ji An Feng
Suzanne Oparil
Tatsuhiko Mori
Tetsuya Hayashi
Yiu-Fai Chen
P2860
P304
P356
10.1046/J.1440-1681.2003.03836.X
P577
2003-05-01T00:00:00Z